Unlock instant, AI-driven research and patent intelligence for your innovation.

Raltitrexed impurity C and preparation and application thereof

A technology of raltitrexed and impurities, applied in the field of medicinal chemistry, can solve the problems of high incidence of toxic and side effects in the blood system, and achieve the effect of reducing side effects

Active Publication Date: 2019-01-29
NANJING CHIA TAI TIANQING PHARMA
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The study found that the reason why raltitrexed has relatively serious blood system side effects has a certain positive correlation with the thiophene impurities in the finished product, that is, the higher the content of the impurity, the higher the blood system toxicity of raltitrexed The higher the incidence of side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Raltitrexed impurity C and preparation and application thereof
  • Raltitrexed impurity C and preparation and application thereof
  • Raltitrexed impurity C and preparation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] The preparation of embodiment 1 impurity C

[0042] ① Preparation of 5-nitro-2-thiophenoyl chloride

[0043] Put 30g of 5-nitro-2-thiophenecarboxylic acid and 50ml of thionyl chloride into a 100ml three-neck flask, raise the temperature, control the internal temperature to 75°C-80°C and stir for 2 hours, take about 1ml of the reaction solution, add 2ml of anhydrous Methanol derivatization, using 5-nitro-2-thiophenecarboxylic acid as a control, TLC detection (ethyl acetate: n-hexane = 1:1) to the end of the reaction. The reaction solution was transferred to a 250ml single-necked bottle, concentrated to dryness, and then dried under reduced pressure by adding 30ml of toluene to obtain green needle crystals.

[0044] ② Preparation of N-(5-nitro-2-thiophenoyl)-L-glutamic acid diethyl ester

[0045] Put 35.0g of L-diethyl glutamate, 150ml of dichloromethane and 12.5ml of diisopropylethylamine into a 250ml three-neck flask, lower the temperature, and slowly add 50ml of dich...

Embodiment 2

[0052] The preparation of embodiment 2 impurity C

[0053] ① Preparation of 5-nitro-2-thiophenoyl chloride

[0054] Put 30g of 5-nitro-2-thiophenecarboxylic acid and 50ml of phosphorus oxychloride into a 100ml three-neck flask, raise the temperature, control the internal temperature to 75°C-80°C and stir for 2 hours, then take about 1ml of the reaction solution and add 2ml of anhydrous methanol Derivatization, using 5-nitro-2-thiophenecarboxylic acid as a control, TLC detection (ethyl acetate: n-hexane = 1:1) to the end of the reaction. The reaction solution was transferred to a 250ml single-necked bottle, concentrated to dryness, and then dried under reduced pressure by adding 30ml of toluene to obtain green needle crystals.

[0055] ② Preparation of N-(5-nitro-2-thiophenoyl)-L-glutamic acid diethyl ester

[0056] Put 35.0g of L-diethyl glutamate, 150ml of dichloromethane and 12.5ml of ethylenediamine into a 250ml three-neck flask, lower the temperature, and slowly add 50ml...

Embodiment 3

[0063] The preparation of embodiment 3 impurity C

[0064] ① Preparation of 5-nitro-2-thiophenoyl chloride

[0065] Put 30g of 5-nitro-2-thiophenecarboxylic acid and 50ml of phosphorus trichloride into a 100ml three-neck flask, raise the temperature, control the internal temperature to 75°C-80°C and stir for 2 hours, then take about 1ml of the reaction solution and add 2ml of anhydrous methanol Derivatization, using 5-nitro-2-thiophenecarboxylic acid as a control, TLC detection (ethyl acetate: n-hexane = 1:1) to the end of the reaction. The reaction solution was transferred to a 250ml single-necked bottle, concentrated to dryness, and then dried under reduced pressure by adding 30ml of toluene to obtain green needle crystals.

[0066] ② Preparation of N-(5-nitro-2-thiophenoyl)-L-glutamic acid diethyl ester

[0067] Put 35.0g of L-diethyl glutamate, 150ml of dichloromethane and 12.5ml of DBU into a 250ml three-necked bottle, lower the temperature, and slowly add 50ml of dichl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a potential blood system toxic impurity C of Raltitrexed, a preparation method thereof, and an application of the impurity C as an impurity reference substance.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and in particular relates to the preparation and application of a new impurity of raltitrexed. Background technique [0002] Raltitrexed (Raltitrexed) is a new generation of water-soluble quinazoline folic acid analogue thymidylate synthase inhibitor developed by Zeneca, UK, and is suitable for advanced colorectal cancer. Inhibition produces anti-tumor effect. Its chemical name is N-[[5-[[(1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl] -L-glutamic acid. The structural formula is as follows: [0003] [0004] Compared with 5-fluorouracil, due to its specific selectivity, its toxic and side effects are significantly reduced, but it still has certain toxicity. According to the results of relevant clinical trials, its main toxic adverse reactions include reversible effects on the gastrointestinal tract, blood system and liver enzymes. [0005] Among them, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D333/38A61K31/517A61K31/381A61P35/00G01N33/15
CPCA61K31/381A61K31/517C07D333/38G01N33/15A61K2300/00
Inventor 徐丹王足兵汪传军郭璇吴晶柴雨柱王华萍朱春霞田舟山
Owner NANJING CHIA TAI TIANQING PHARMA